CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-22 | ROBIN HOWARD W President & CEO | Option exercise | +33,334 | $7.21 | $240K | 328,660 |
| 2019-05-22 | ROBIN HOWARD W President & CEO | Sale | −33,334 | $33.38 | $1.1M | 295,326 |
| 2019-05-22 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,334 | 33,333 | ||
| 2019-05-21 | ROBIN HOWARD W President & CEO | Option exercise | +33,333 | $7.21 | $240K | 328,659 |
| 2019-05-21 | ROBIN HOWARD W President & CEO | Sale | −33,333 | $32.93 | $1.1M | 295,326 |
| 2019-05-21 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,333 | 66,667 | ||
| 2019-05-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −1,928 | $31.37 | $60K | 164,463 |
| 2019-05-16 | ROBIN HOWARD W President & CEO | Sale | −13,383 | $31.37 | $420K | 295,326 |
| 2019-05-16 | Nicholson John SVP & Chief Operating Officer | Sale | −4,077 | $31.37 | $128K | 166,578 |
| 2019-05-16 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −3,767 | $31.37 | $118K | 127,935 |
| 2019-05-16 | Hora Maninder SVP Pharma Dev & Mfg Ops | Sale | −2,449 | $31.37 | $77K | 94,694 |
| 2019-05-16 | Doberstein Stephen K SVP & Chief Scientific Officer | Sale | −3,461 | $31.37 | $109K | 95,913 |
| 2019-03-08 | GREER R SCOTT Director | Option exercise | +10,000 | $5.14 | $51K | 145,083 |
| 2019-03-08 | GREER R SCOTT Director | Option exercise · Stock Option | −10,000 | 0 | ||
| 2019-02-21 | ROBIN HOWARD W President & CEO | Option exercise | +33,333 | $7.21 | $240K | 342,042 |
| 2019-02-21 | ROBIN HOWARD W President & CEO | Sale | −33,333 | $41.01 | $1.4M | 308,709 |
| 2019-02-21 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,333 | 100,000 | ||
| 2019-02-20 | ROBIN HOWARD W President & CEO | Option exercise | +33,334 | $7.21 | $240K | 342,043 |
| 2019-02-20 | ROBIN HOWARD W President & CEO | Sale | −33,334 | $43.20 | $1.4M | 308,709 |
| 2019-02-20 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,334 | 133,333 |
Page 26 of 29 · 562 trades